Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cell Source (CLCS)
:CLCS
Holding CLCS?
Track your performance easily
CLCS Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.14 - $0.84
Previous CloseN/A
Volume3.40K
Average Volume (3M)13.37K
Market Cap
$17.30M
Enterprise ValueN/A
Total Cash (Recent Filing)$3.73K
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-171.47
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.16
Shares Outstanding43,468,185
10 Day Avg. Volume20,760
30 Day Avg. Volume13,366
Standard Deviation74.07
R-Squared0.01
Alpha16.88
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-6.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
CLCS FAQ
What was Cell Source ’s price range in the past 12 months?
Cell Source lowest stock price was $0.14 and its highest was $0.84 in the past 12 months.
What is Cell Source ’s market cap?
Cell Source ’s market cap is $17.30M.
When is Cell Source ’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Cell Source ’s earnings last quarter?
Currently, no data Available
Is Cell Source overvalued?
According to Wall Street analysts Cell Source ’s price is currently Overvalued.
Does Cell Source pay dividends?
Cell Source does not currently pay dividends.
What is Cell Source ’s EPS estimate?
Cell Source ’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cell Source have?
Cell Source has 43,468,185 shares outstanding.
What happened to Cell Source ’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Cell Source ?
Currently, no hedge funds are holding shares in CLCS
---
Company Description
Cell Source
Cell Source, Inc. is a biotechnology company, which engages in the development of cell therapy treatments based on the management of immune tolerance. The firm's lead product, Veto-Cell immune system management technology, which is an immune tolerance biotechnology that enables the selective blocking of immune responses. The company was founded on June 6, 2012 and is headquartered in New York, NY.
---
Technical Analysis
---